Karas Eric

Track

Insider profile

Karas Eric's trades of ARS Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
390.04
Quantity 5,114
Value US$3,993,719
Transaction date
Proposed sale
Price
112.39
Quantity 22,581
Value US$2,008,751
Transaction date
Proposed sale
Price
94.69
Quantity 62,482
Value US$2,485,923
Transaction date
Proposed sale
Price
4.96
Quantity 14,064
Value US$69,762
Transaction date
Proposed sale
Price
10.00
Quantity 25,000
Value US$250,000
Transaction date
Proposed sale
Price
16.99
Quantity 15,000
Value US$254,859
Transaction date
Proposed sale
Price
16.00
Quantity 15,000
Value US$240,000
Transaction date
Proposed sale
Price
14.00
Quantity 10,000
Value US$140,000
Transaction date
Proposed sale
Price
14.00
Quantity 6,283
Value US$87,962
Transaction date
Proposed sale
Price
14.11
Quantity 3,717
Value US$52,461
Transaction date
Proposed sale
Price
14.00
Quantity 10,000
Value US$140,000
Transaction date
Proposed sale
Price
14.00
Quantity 10,000
Value US$140,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-19 2026-10-19
PrS Proposed sale
5,114
390.04
US$3,993,719 		5,114 390.04 US$3,993,719
2026-10-01 2026-10-01
PrS Proposed sale
22,581
112.39
US$2,008,751 		22,581 112.39 US$2,008,751
2026-09-30 2026-09-30
PrS Proposed sale
62,482
94.69
US$2,485,923 		62,482 94.69 US$2,485,923
2026-09-11 2026-09-11
PrS Proposed sale
14,064
4.96
US$69,762 		14,064 4.96 US$69,762
2026-06-12 2026-06-12
PlS Planned sale
25,000 -67.2%
10.00
US$250,000 		25,000 -67.2% 10.00 US$250,000
2026-06-12 2026-06-12
PrS Proposed sale
25,000
10.00
US$250,000 		25,000 10.00 US$250,000
2025-07-03 2025-07-01
PlS Planned sale
15,000 -59.3%
16.99
US$254,860 		15,000 -59.3% 16.99 US$254,860
2025-07-01 2025-07-01
PrS Proposed sale
15,000
16.99
US$254,859 		15,000 16.99 US$254,859
2025-06-20 2025-06-18
PlS Planned sale
15,000 -66.1%
16.00
US$240,000 		15,000 -66.1% 16.00 US$240,000
2025-06-18 2025-06-18
PrS Proposed sale
15,000
16.00
US$240,000 		15,000 16.00 US$240,000
2025-03-21 2025-03-20
PlS Planned sale
10,000 -56.5%
14.00
US$140,000 		10,000 -56.5% 14.00 US$140,000
2025-03-20 2025-03-20
PrS Proposed sale
10,000
14.00
US$140,000 		10,000 14.00 US$140,000
2024-12-04 2024-12-04
PrS Proposed sale
6,283
14.00
US$87,962 		6,283 14.00 US$87,962
2024-12-04 2024-12-04
PlS Planned sale
6,283 -52.5%
14.00
US$87,962 		6,283 -52.5% 14.00 US$87,962
2024-12-04 2024-12-02
PlS Planned sale
3,717 -39.5%
14.11
US$52,461 		3,717 -39.5% 14.11 US$52,461
2024-12-02 2024-12-02
PrS Proposed sale
3,717
14.11
US$52,461 		3,717 14.11 US$52,461
2024-09-19 2024-09-18
PlS Planned sale
10,000 -63.7%
14.00
US$140,000 		10,000 -63.7% 14.00 US$140,000
2024-09-18 2024-09-18
PrS Proposed sale
10,000
14.00
US$140,000 		10,000 14.00 US$140,000
2024-08-21 2024-08-19
PlS Planned sale
10,000 -63.7%
14.00
US$140,000 		10,000 -63.7% 14.00 US$140,000
2024-08-19 2024-08-19
PrS Proposed sale
10,000
14.00
US$140,000 		10,000 14.00 US$140,000